Being close enough to patients to care is as critical as remaining distant enough from a pathogen to be safe. This strategy simultaneously frustrates and supports public trust.
AMA J Ethics. 2020; 22(1):E22-27. doi:
10.1001/amajethics.2020.22.
How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?
AMA J Ethics. 2020; 22(1):E43-49. doi:
10.1001/amajethics.2020.43.
Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
As larger organizations become more influential in the health care sector, the Code can help physicians navigate those organizations’ influence on their practices.
AMA J Ethics. 2020; 22(3):E217-220. doi:
10.1001/amajethics.2020.217.
Upcoding and misrepresenting clinical information constitute fraud, cost a lot, and can result in patient harm and unnecessary procedures and prescriptions.
AMA J Ethics. 2020; 22(3):E221-231. doi:
10.1001/amajethics.2020.221.
When we approach art with awe and treat medicine as serious business, perhaps we’re depriving ourselves of the funniest tool in the health and wellness toolbox.
AMA J Ethics. 2020; 22(7):E624-627. doi:
10.1001/amajethics.2020.624.
Professor john powell joins us for this special edition of Ethics Talk to discuss how a lens of “othering and belonging” can help us navigate our obligations to and relationships with each other, especially during this COVID-19 pandemic.